Skip to content

13F-HR filed by MFN Partners Management, LP

MFN Partners Management, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-12, with 10 holding rows worth $2,949,352,087.

Accession
0000904454-24-000456
Filed
2024-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 10 entries on the cover page, a total value of $2,949,352,087 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,949,352,087 with VALUE read as dollars as filed, 13F file number 028-19231. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
XPO INC COM983793100Stock11,425,369$1,212,802,919dollars as filed
RXO, Inc.74982T103Common Stock, $0.01 par value17,310,856$452,678,885dollars as filed
PENNYMAC FINL SVCS INC NEW70932M107COM4,531,792$428,707,523dollars as filed
HCA Healthcare Inc40412C101COM973,898$312,893,949dollars as filed
OCCIDENTAL PETE CORP WT EXP 080327674599162Stock5,690,600$234,225,096dollars as filed
LITHIA MTRS INC COM536797103Stock890,000$224,680,500dollars as filed
BAUSCH HEALTH COS INC COM071734107Stock6,000,000$41,820,000dollars as filed
IVANHOE ELECTRIC INC US46578C108COMMON STOCK2,553,191$23,948,932dollars as filed
FORWARD AIR CORP349853101COM903,777$17,207,914dollars as filed
Cyclerion Therapeutics Inc23255M204COM169,460$386,369dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-24-000456this filing2024-08-12acceptance time not in the bulk data set